文献速递血栓与止血

医院获得性静脉血栓风险模型的开发与验证:内科住院患者血栓与止血研究

Development and validation of a risk model for hospital-acquired venous thrombosis: the Medical Inpatients Thrombosis and Hemostasis study.
PubMed 文献 · J Thromb Haemost · 2023-10-31

该研究利用2010至2019年佛蒙特大学医学中心内科住院患者开发队列及三个外部验证队列,构建并验证了基于入院时可获取客观指标的内科住院患者医院获得性静脉血栓栓塞风险模型。模型纳入7个风险因素,开发队列AUC为0.72、校准斜率为1.10,三个验证队列AUC为0.70至0.71。

要点

  • 模型纳入7个入院时可获取的客观风险因素:静脉血栓史、低血红蛋白、肌酐升高、活动性癌症、低钠血症、红细胞分布宽度升高、营养不良。
  • 开发队列60 633例次入院、227例医院获得性静脉血栓栓塞,AUC 0.72、校准斜率1.10。
  • 三个外部验证队列AUC为0.70至0.71,按年龄、性别和种族分层表现良好。

核心结论

  • 研究开发并验证了用于内科住院患者的医院获得性静脉血栓栓塞风险模型,通过量化风险帮助临床医生判断降低医院获得性静脉血栓栓塞措施的潜在获益。

研究设计与样本

  • 开发队列纳入2010至2019年佛蒙特大学医学中心内科收治患者,验证队列纳入亨内平县医学中心、密歇根大学医学中心和哈里斯健康系统的内科收治患者。
  • 排除入院时已存在静脉血栓栓塞、年龄小于18岁及住院不足1个午夜的患者。
  • 采用贝叶斯惩罚回归技术筛选候选医院获得性静脉血栓栓塞风险因素以最终纳入风险模型。
  • 开发队列包含60 633例次入院和227例医院获得性静脉血栓栓塞,验证队列包含111 269例次入院和651例医院获得性静脉血栓栓塞。

主要发现

  • 7个t统计量≥1.5的医院获得性静脉血栓栓塞风险因素纳入风险模型:静脉血栓史、低血红蛋白水平、肌酐水平升高、活动性癌症、低钠血症、红细胞分布宽度升高和营养不良。
  • 开发队列的受试者工作特征曲线下面积和校准斜率分别为0.72和1.10。
  • 亨内平县医学中心的受试者工作特征曲线下面积和校准斜率分别为0.70和0.93。
  • 密歇根大学医学中心的受试者工作特征曲线下面积和校准斜率分别为0.70和0.87。
  • 哈里斯健康系统的受试者工作特征曲线下面积和校准斜率分别为0.71和1.00;风险模型按年龄、性别和种族分层表现良好。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Regulatory organizations recommend assessing hospital-acquired (HA) venous thromboembolism (VTE) risk for medical inpatients. OBJECTIVES: To develop and validate a risk assessment model (RAM) for HA-VTE in medical inpatients using objective and assessable risk factors knowable at admission. METHODS: The development cohort included people admitted to medical services at the University of Vermont Medical Center (Burlington, Vermont) between 2010 and 2019, and the validation cohorts included people admitted to Hennepin County Medical Center (Minneapolis, Minnesota), University of Michigan Medical Center (Ann Arbor, Michigan), and Harris Health Systems (Houston, Texas). Individuals with VTE at admission, aged <18 years, and admitted for <1 midnight were excluded. We used a Bayesian penalized regression technique to select candidate HA-VTE risk factors for final inclusion in the RAM. RESULTS: The development cohort included 60 633 admissions and 227 HA-VTE, and the validation cohorts included 111 269 admissions and 651 HA-VTE. Seven HA-VTE risk factors with t statistics ≥1.5 were included in the RAM: history of VTE, low hemoglobin level, elevated creatinine level, active cancer, hyponatremia, increased red cell distribution width, and malnutrition. The areas under the receiver operating characteristic curve and calibration slope were 0.72 and 1.10, respectively. The areas under the receiver operating characteristic curve and calibration slope were 0.70 and 0.93 at Hennepin County Medical Center, 0.70 and 0.87 at the University of Michigan Medical Center, and 0.71 and 1.00 at Harris Health Systems, respectively. The RAM performed well stratified by age, sex, and race. CONCLUSION: We developed and validated a RAM for HA-VTE in medical inpatients. By quantifying risk, clinicians can determine the potential benefits of measures to reduce HA-VTE.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Zakai NA, Wilkinson K, Sparks AD, et al. Development and validation of a risk model for hospital-acquired venous thrombosis: the Medical Inpatients Thrombosis and Hemostasis study. J Thromb Haemost. 2023. PMID: 37918635. doi:10.1016/j.jtha.2023.10.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。